Article Versions Notes

Barajas RF, Krohn KA, Link JM, Hawkins RA, Clarke JL, Pampaloni MH, Cha S. Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine. Biomedicines. 2016; 4(4):24. https://doi.org/10.3390/biomedicines4040024

Barajas, Ramon F., Kenneth A. Krohn, Jeanne M. Link, Randall A. Hawkins, Jennifer L. Clarke, Miguel H. Pampaloni, and Soonmee Cha. 2016. "Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine" Biomedicines 4, no. 4: 24. https://doi.org/10.3390/biomedicines4040024

Barajas, R. F., Krohn, K. A., Link, J. M., Hawkins, R. A., Clarke, J. L., Pampaloni, M. H., & Cha, S. (2016). Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine. Biomedicines, 4(4), 24. https://doi.org/10.3390/biomedicines4040024